Table 3.
Progression-free survival | Overall survival | |||
---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | |
Median age, top group | 11.1 (2.0–61.2) | 0.006 | 22.7 (2.6–195.2) | 0.004 |
Stage, III-IV | 38.6 (6.5–228.0) | < 0.001 | 5.8 (1.8–18.3) | 0.003 |
Furhman grade, 3–4 | 12.7 (3.2–50.1) | < 0.001 | – | – |
Surgical margins, negative | – | – | 0.1 (0.02–0.4) | 0.001 |
PRATt, top tertile | – | – | 0.3 (0.1–0.7) | 0.009 |
PRATcl, top tertile | 0.3 (0.1–0.8) | 0.019 | – | – |
PRATt, perirenal adipose tissue tumor side; PRATcl, perirenal adipose tissue contralateral side.